Background Prenatal stress may alter immune competence of the fetus. Limited data exist on the role of antenatal stress in psoriasis development. Objectives To investigate whether prenatal exposure to maternal bereavement increases the risk of offspring psoriasis. Methods This register-based cohort study included 1 811 917 live singletons born from 1978 to 2008 in Denmark. The children were assigned to the bereaved group if their mothers lost a child, partner/spouse, parent or sibling during pregnancy or up to 12 months before pregnancy. Follow-up started at the date of birth and ended at the date of first hospital treatment for psoriasis or a prescription redeemed for topical vitamin D derivatives (often used to treat psoriasis), emigration, death or 31 December 2010, whichever came first. We evaluated the hazard ratio (HR) of psoriasis in bereaved children using Cox proportional hazards regressions, compared with the nonbereaved group. Results During 28 million person-years of follow-up, 7956 children were hospitalized or prescribed medications for psoriasis. By the age of 30 years, 1Á54% [95% confidence interval (CI) 1Á25-1Á90%] of children from the bereaved group were diagnosed with psoriasis, compared with 1Á34% (95% CI 1Á30-1Á38%) of nonbereaved children. Overall, prenatal exposure to maternal bereavement was not associated with risk of psoriasis in general (HR 1Á05, 95% CI 0Á91-1Á20). However, children born to mothers who lost a partner/spouse or an older child had an increased risk of psoriasis (HR 1Á33, 95% CI 1Á02-1Á73). Conclusions Prenatal exposure to the most stressful life event may contribute to the development and/or exacerbation of psoriasis.
Summary
Background Prenatal stress may alter immune competence of the fetus. Limited data exist on the role of antenatal stress in psoriasis development. Objectives To investigate whether prenatal exposure to maternal bereavement increases the risk of offspring psoriasis. Methods This register-based cohort study included 1 811 917 live singletons born from 1978 to 2008 in Denmark. The children were assigned to the bereaved group if their mothers lost a child, partner/spouse, parent or sibling during pregnancy or up to 12 months before pregnancy. Follow-up started at the date of birth and ended at the date of first hospital treatment for psoriasis or a prescription redeemed for topical vitamin D derivatives (often used to treat psoriasis), emigration, death or 31 December 2010, whichever came first. We evaluated the hazard ratio (HR) of psoriasis in bereaved children using Cox proportional hazards regressions, compared with the nonbereaved group. Results During 28 million person-years of follow-up, 7956 children were hospitalized or prescribed medications for psoriasis. By the age of 30 years, 1Á54% [95% confidence interval (CI) 1Á25-1Á90%] of children from the bereaved group were diagnosed with psoriasis, compared with 1Á34% (95% CI 1Á30-1Á38%) of nonbereaved children. Overall, prenatal exposure to maternal bereavement was not associated with risk of psoriasis in general (HR 1Á05, 95% CI 0Á91-1Á20). However, children born to mothers who lost a partner/spouse or an older child had an increased risk of psoriasis (HR 1Á33, 95% CI 1Á02-1Á73). Conclusions Prenatal exposure to the most stressful life event may contribute to the development and/or exacerbation of psoriasis.
What's already known about this topic?
• Psoriasis is a common, chronic inflammatory disease, which is believed to be mediated by T helper (Th)1 and Th17 cells.
• Psychological stress regulates the hypothalamic-pituitary-adrenal (HPA) axis and alters immune competence in favour of Th17 cells, thus triggering the development/exacerbation of psoriasis.
• Prenatal exposure to maternal stress can activate the HPA axis of the offspring. So far, there is a paucity of epidemiological data on whether prenatal stress increases risk of psoriasis.
What does this study add?
• This population-based study comprised 1 811 917 singletons, of which 47 279 were born to bereaved mothers.
• By the age of 30 years, 1Á54% of children from the bereaved group were diagnosed with psoriasis, compared with 1Á34% of children from the nonbereaved group.
• Prenatal stress following maternal loss of an elder child or partner/spouse during pregnancy, the most stressful life event, increases the risk of psoriasis development (hazard ratio 1Á33, 95% confidence interval 1Á02-1Á73).
Psoriasis is a common, chronic inflammatory disease of the skin and joints, with a prevalence of 2-3% in the population, 1 varying across ethnic background and geographical location. Psoriasis affects the well-being of patients 2 and impairs healthrelated quality of life, even among patients in whom only limited parts of the body are affected. 3 Moreover, psoriasis confers an independent risk for other serious clinical conditions, such as cardiovascular morbidity and mortality, [4] [5] [6] leading to substantial costs in health expenditure and a huge burden for society. 7 Despite tremendous progress in identifying inflammatory pathways in psoriasis development, there are still significant gaps in our understanding of the aetiology. Psoriasis is believed to be induced by T helper (Th)1 and Th17 lymphocytes. 8 Along with genetic predisposition, 9 psychological stress is expected to precipitate and exacerbate psoriasis. 10 Stress can regulate the action of the hypothalamic-pituitary-adrenal (HPA) axis and stimulate release of corticotrophin-releasing hormone, to regulate the secretory function of mast cells.
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Mast cells can enhance the development of Th17 cells, 12 giving rise to psoriatic lesions. Maternal stress during pregnancy might activate the HPA axis of the offspring and increase the release of corticotrophin-releasing hormone, 13 implicating a possible relationship between prenatal stress and psoriasis in the offspring. So far, there is a paucity of epidemiological data on this topic.
We conducted a population-based longitudinal study using Danish national registers to investigate the association between prenatal stress and offspring psoriasis. The death of a family member is considered to be the most stressful of all life events. 14 We hypothesized that prenatal stress following maternal loss of a close family member increased the risk of psoriasis in the offspring. In this study, we aimed to examine whether children born to mothers who lost a close relative 1 year prior to or during the index pregnancy, the marker of prenatal stress in our study, had an increased risk of psoriasis later in life. Furthermore, we investigated whether the association between prenatal exposure to maternal bereavement and psoriasis was affected by the cause of death and mother's relationship to the deceased.
Materials and methods

Study population
This was a population-based cohort study. to 2008 were identified (n = 1 866 660) to ensure they were representative of the study population. We excluded 76 children who could not be linked to their biological mothers, 527 children with no information on parity, and 54 140 children who had missing or likely errors in gestational age (gestational age < 22 weeks or > 45 weeks). Applying these exclusion criteria yielded a sample of 1 811 917 children born to 974 694 mothers.
Bereavement
Information on bereavement was extracted from the Danish Registers of Causes of Death. 17 In this register, causes of death were coded based on the International Classification of Diseases (ICD). During 1977 to 1993, ICD-8 codes were used to code the diseases and ICD-10 from 1994 onwards in all Danish registers using ICD codes. We identified 47 279 children as the bereaved group, whose mothers lost an older child, partner/spouse, parent or sibling during the index pregnancy or up to 12 months before the pregnancy. The remaining 1 764 638 children consisted of the nonbereaved group (the comparison group). The starting date of pregnancy was estimated using birth date and gestational age. In Denmark, gestational age was previously only estimated by date of last menstrual period, but for the last 20 years, gestational age was adjusted by ultrasonography if necessary. When multiple losses occurred, the first bereavement was used to classify the exposure status.
Identification of psoriasis in the offspring: outcome of interest
Children were classified as having psoriasis if they had visited hospital due to psoriasis identified from the Danish National Patient Register or were dispensed at least one prescription for topical vitamin D derivatives from the Danish National Prescription Registry. 18, 19 The Danish National Patient Register has records on all inpatient treatment since 1977, and from 1995 also for all emergency room and outpatient contacts. 18 The following ICD codes were used: psoriasis (ICD-8 The anatomical therapeutic chemical (ATC) code for topical vitamin D derivatives was D05AX. Topical vitamin D derivatives are used as the first-line pharmaceutical treatment for psoriasis exclusively 20 and are not available without a prescription in Denmark. The first diagnosis of psoriasis was defined as the date of first admission, emergency room visit or outpatient treatment for psoriasis or first prescription redeemed for topical vitamin D derivatives, whichever came first. We likewise retrieved the data on maternal history, paternal history, maternal family history (in father, mother or sibling of the mother) and paternal family history (in father, mother or sibling of the father) of ever psoriasis before the index pregnancy.
Follow-up
We followed the children from birth to the first hospital treatment for psoriasis or first prescription redeemed for topical vitamin D derivatives in the registers, emigration, death or the end of 2010, whichever came first.
Statistical analysis
Statistical analyses were performed in SAS 9.4 (SAS Institute Inc., Cary, NC, U.S.A.). We employed Kaplan-Meier curves to illustrate the absolute risk of psoriasis. We used a Cox proportional hazards regression model to calculate the hazard ratios (HRs) with 95% confidence intervals (CIs) for psoriasis in children whose mothers lost a close relative during pregnancy or up to 12 months prior to the index pregnancy. Proportionality was evaluated by visual inspection of log-log plots. The assumption of proportional hazards ratios was met for our data. We used robust standard errors to adjust for dependency between siblings in the analysis. All P-values were based on Wald tests, and P < 0Á05 (two-sided test) was considered statistically significant. Missing values were included in the models as separate groups.
Adjustment was made for the following potential covariates supposed to be associated with maternal bereavement and psoriasis, determined based on the directed acyclic graph:
21 maternal age at delivery (< 25, 25-34 or ≥ 35 years), parity (first, second and higher), maternal education (≤ 9, 10-14 or ≥ 15 years), maternal marital status (single/divorced/widowed, or married), maternal social status (not in the labour market, blue collar workers, white collar workers or higher position workers), maternal country of origin (Nordic countries or other countries), calendar year of birth (1978-1987, 1988-1997 or 1998-2008) , maternal history of psoriasis (yes/no), paternal history of psoriasis (yes/no), maternal family history of psoriasis (yes/no), and paternal family history of psoriasis (yes/no). Information on the sex of the child, calendar year of birth, parity and maternal age at delivery was retrieved from the Danish Medical Birth Registry, 16 and maternal marital status from the Danish Civil Registration System. 15 Information on maternal education, social status and country of origin was obtained from the Danish Integrated Database for Longitudinal Labor Market Research. 22 To examine whether the association between maternal bereavement and psoriasis depended on the mother's relationship to the deceased, we categorized bereaved children into three groups (maternal loss of an older child/partner/spouse, a parent or a sibling). To estimate the effects of timing of bereavement, we categorized the exposure window into the following five periods: 7-12 months before pregnancy; 0-6 months before pregnancy; first trimester; second trimester; and third trimester. We further categorized the cause of death into two groups: unexpected death (795, E800-999 in ICD-8; R95-97, V00-Y99 in ICD-10), and other causes of death. To see whether or not there was a dose-response relationship between frequencies of maternal bereavement and psoriasis, we grouped frequencies of bereavement into two groups: once and multiple losses.
There may be a sex-specific interplay between the mother, placenta and the fetus. 23 To see whether or not the association of maternal bereavement with psoriasis was modified by sex, the analysis was repeated, stratifying by sex of the child. It is postulated that obesity, usually measured by body mass index (BMI), tends to aggregate within families. 24 Obesity has been shown to be associated with increased risk of premature mortality (the exposure), 25 and is also related to psoriasis (the outcome). 26 Maternal BMI may thus be a potential cofounder for our study. We therefore performed a sensitivity analysis by further adjustment for prepregnancy BMI (< 25Á0, 25Á0-29Á9 or ≥ 30Á0 kg m À2 ), retrieved from the Danish National Birth Cohort. 27 To evaluate whether the associations were modified by family history of psoriasis, we estimated the association separately in children with a negative parental history of psoriasis.
Ethics
The study was approved by Danish Data Protection Agency (J.nr. 2013-41-2569). According to Danish legislation no informed consent is required for a register-based study on the basis of anonymized data.
Results Table 1 presents the baseline characteristics of the study population. Altogether 47 279 children (2Á6%) were born to mothers who lost a close relative prenatally, and 886 children to mothers who experienced more than one loss. Bereaved mothers tended to be multiparous and to have a child at an older age at the time of the index child's birth, in comparison with the nonbereaved mother. The bereaved group was comparable with the nonbereaved group regarding maternal education, marital status, social status, country of origin, maternal psoriasis history, paternal psoriasis history, maternal family history of psoriasis and paternal family history of psoriasis. During 28 million person-years of follow-up [median 15Á6 years per person; interquartile range (IQR) 8Á4-22Á7 years], 7956 children were diagnosed with psoriasis. The mean age at psoriasis onset was 17Á0 AE 7Á0 years (median 17Á2; IQR 12Á0-22Á1) for nonbereaved children and 16Á2 AE 7Á0 years (median 16Á5; IQR 11Á4-21Á1) for children from the bereaved group. Figure 1 shows, using Kaplan-Meier curves, the cumulative incidence rate of psoriasis in bereaved and nonbereaved children. By the age of 30 years, 1Á54% (95% CI 1Á25-1Á90%) of children from the bereaved group were diagnosed with psoriasis, in comparison with 1Á34% (95% CI 1Á30-1Á38%) of nonbereaved children.
Prenatal exposure to maternal bereavement was not associated with the risk of psoriasis in general; the HR was 1Á05 (95% CI 0Á91-1Á20). The risk was not modified by the timing of bereavement. An increased HR of 1Á33 (95% CI 1Á02-1Á73) was observed among children whose mothers lost a partner or an elder child. There was no evidence that the association was modified by the causes of death or frequencies of death (Table 2) .
When we stratified by the sex of the child, the HR of psoriasis was 1Á08 (95% CI 0Á87-1Á32) for bereaved boys compared with nonbereaved boys, and 1Á02 (95% CI 0Á84-1Á23) for bereaved girls compared with nonbereaved girls, respectively (P-value 0Á81 for interaction between bereavement and sex of the child). The HRs of psoriasis for bereaved children were 1Á04 (95% CI 0Á68-1Á59) and 1Á03 (95% CI 0Á67-1Á59) with and without further adjustment for prepregnancy BMI in the subgroup analysis, compared with nonbereaved children, respectively. Similar associations were observed when we estimated the association in children with a negative parental history of psoriasis (Table 3) .
Discussion
This nationwide cohort study demonstrated that maternal bereavement during pregnancy was not strongly related to an increased risk of psoriasis in the offspring in general, but the loss of the partner/spouse or an older child was associated with an increased risk of psoriasis. The death of a child and suicidal death of the partner/spouse are the most severe sources of stress (i.e. catastrophic life events) 14 and therefore may have a different effect on psoriasis than the loss of other relatives. Evidence indicates that psoriasis and cardiovascular disease may share common pathogenic pathways. 28 Our previous study observed an increased risk of cardiovascular disease among children born to mothers who experienced bereavement during the index pregnancy. 29 Analogously, it is possible that prenatal stress may also trigger the development of psoriasis. Our finding of an increased risk of psoriasis in children whose mothers lost an older child or partner/spouse confirms this theory. Although the mechanisms underlying the association remain unclear, our finding is supported by two potential biological mechanisms. Firstly, children exposed to maternal stress in utero have an altered HPA axis function after birth and enhanced level of corticotrophin-releasing hormone. 30 Corticotrophin-releasing hormone subsequently regulates the secretory function of mast cells, which in turn counteract regulatory T-cell inhibition over effector T cells in favour of Th17-mediated inflammatory responses. 12 Secondly, pregnant women experiencing stress have increased levels of proinflammatory cytokines such as tumour necrosis factor-a and interleukin (IL)-6. 31,32 IL-6 can cross the placenta, 33 and activate myeloid dendritic cells of the fetus. Cumulative incidence rate of psoriasis and induce proinflammatory cytokines, 34 precipitating the development of psoriasis. 28 These two pathways are not mutually exclusive and might coexist. For instance, mast cells, in the presence of IL-6, suppress regulatory T cells. 12 In addition to biological explanations, antenatal bereavement may affect psoriasis by influencing maternal behaviour both during pregnancy and after delivery. [35] [36] [37] Depressed mothers may be more anxious and would tend to notice the symptoms of psoriasis and seek medical treatment for their children. However, there was no difference in the cumulative incidence rate before 10 years of age between children from the bereaved group and nonbereaved children, indicating that the increased risk is unlikely due to earlier unmasking. This study has some strengths and limitations. Even though the effects of maternal bereavement during pregnancy on offspring outcomes are well examined, the literature of the association with psoriasis examined in our current study is sparse. Important strengths of the present study included its being representative of the Danish population, large sample size and the ability to detect even a moderate effect on psoriasis of prenatal exposure to bereavement. The complete follow-up minimizes the possibility of selection bias. Information on bereavement and the diagnosis of psoriasis were collected prospectively, which reduces the chance of information bias due to different reporting. The availability of information on some covariates enables us to control for some potential confounders when studying the association with psoriasis of prenatal stress due to maternal bereavement.
Several limitations need to be acknowledged. Firstly, we used the date of bereavement as the indicator of the start of stress exposure. Except for sudden/unexpected death, it is quite challenging to determine the accurate start time of stress exposure due to bereavement. Therefore, our data may not be suitable for exploring the trimester-specific effect in our study. Secondly, because we used hospital treatment for psoriasis and a redemption for a prescription for vitamin D claims to identify patients with psoriasis, patients treated with other pharmaceutical treatments may not be included in our study. A previous study validated the method of identifying psoriasis patients using the prescription for vitamin D derivatives. They examined 155 patients with psoriasis identified from hospital records and found 73Á5% of them had a history of vitamin D derivative use. 38 The combination of hospital records and prescription data enabled us to find most, but not all, of the psoriasis cases. The misclassification is thought to be minor and nondifferential, and will lead to an underestimation of the association. 39 Thirdly, accurate determination of the age of psoriasis onset is problematic as small lesions may be present for years before the disease is diagnosed. 40 These misclassifications are, again, nondifferential and will bias our finding toward the null. Fourthly, although we adjusted for several covariates in our models, we cannot rule out residual confounding by unmeasured factors. Also, there are only limited studies performed in newborns or pregnant women to support the underlying mechanisms we have described above. Further studies are warranted to replicate our finding. Fifthly, our study focused on the Danish population with a follow-up time up to 30 years. There are two peaks in the occurrence of psoriasis: one between 16 and 22 years and the other between 57 and 60 years of age. 41 As the maximum follow- Table 3 Hazard ratios (HRs) for psoriasis events in the offspring with a negative parental history of psoriasis according to the timing of bereavement, mother's relationship to the deceased, causes of death and frequencies of bereavement up time in our study is 30 years, we can only investigate early-onset psoriasis; 42 therefore, our findings are not generalizable to late-onset psoriasis. Furthermore, psoriasis is a heterogeneous disease with a strong genetic component. Therefore, it may not be possible to extrapolate our findings to other populations.
In conclusion, in this population-based cohort study we found that prenatal stress following the loss of a close family member did not increase the risk of offspring psoriasis in general. Children born to mothers who lost a partner/spouse or an older child during pregnancy were associated with increased risk of psoriasis. Our study provided some evidence that prenatal exposure to the most stressful life event may contribute to the development and/or exacerbation of psoriasis in the offspring.
